The expanding restatement scope signals deep-seated accounting control issues and elevated SEC scrutiny. Traders should expect further volatility, potential shareholder lawsuits, and possible OTC delisting if the company fails to file timely accurate financials. Avoid long positions until credible remediation and clean audits are demonstrated.
Price Chart
Executive Summary
FDCTech's Board concluded that all 2024 interim financial statements (Q1, Q2, Q3) can no longer be relied upon, expanding the prior restatement to include these periods. This was prompted by an SEC comment letter and adds to a series of accounting errors, further undermining investor confidence in the company's financial reporting.
Key Facts
- Board determined non-reliance on all unaudited 2024 interim financial statements (Q1, Q2, Q3 2024).
- SEC Division of Corporation Finance comment letter (June 18, 2026) requested addressing whether FY2024 restatement affected interim periods.
- Errors include misclassification of client funds, related party advances, subscription receivable, omission of 500,000 shares, and intercompany elimination errors.
- Material weaknesses in internal control over financial reporting continue.
- Prior auditor (Olayinka Oyebola & Co.) dismissed April 2025; LAO Professionals now engaged.
- Restated comparative information will be available in FY2025 10-Q amendments, not separate 2024 amendments.
Financial Impact
Prior restatement adjustments for FY2024 included $280,690 increase in total assets and $14,366 increase in net income; impact on interim periods not separately quantified but likely similar magnitude.
Risk Factors
- Expanded SEC investigation or enforcement action
- Shareholder class-action lawsuits (almost certain given serial restatements)
- Delisting from OTC Markets if filing compliance fails
- Going-concern risk due to auditor churn and control failures
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-029812 |
| Document: 0001493152-26-029812-index-headers.html | 0001493152-26-029812 |
| Document: 0001493152-26-029812-index.html | 0001493152-26-029812 |
| Document: 0001493152-26-029812.txt | 0001493152-26-029812 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 14, 2026 13d ago | 8-K | $3.99 | awaiting T+60 | — | $4.37 (+9.52%) |
Oct 2, 2026 25d ago | EFFECT | $2.01 | awaiting T+60 | — | $4.37 (+117.41%) |
Sep 24, 2026 4w ago | S-1/A | $2.85 | awaiting T+60 | — | $4.37 (+53.33%) |
Sep 22, 2026 5w ago | 8-K | $2.10 | awaiting T+60 | — | $4.37 (+108.10%) |
Sep 15, 2026 6w ago | S-1 | $0.9900 | awaiting T+60 | — | $4.37 (+341.41%) |
Sep 10, 2026 6w ago | 8-K | $0.9999 | awaiting T+60 | — | $4.37 (+337.04%) |
Aug 26, 2026 8w ago | 8-K | $1.25 | awaiting T+60 | — | $4.37 (−249.60%) |
Jun 23, 2026 17w ago | 8-K | $3.11 $0.9900 | ▲ +68.17% | ▲ +71.46% | $4.37 (−40.51%) |
Jun 23, 2026 17w ago | 10-K/A | $3.11 $0.9900 | ▲ +68.17% | ▲ +71.46% | $4.37 (−40.51%) |
Jun 8, 2026 20w ago | 8-K | $6.00 $1.00 | ▲ +83.33% | ▲ +87.41% | $4.37 (+27.17%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers